The role of GLP-1 in cardiac recovery after bariatric surgery in obesity-induced heart failure

GLP-1 在肥胖引起的心力衰竭减肥手术后心脏恢复中的作用

• 批准号: 10080367
• 负责人: Tammy Lyn Kindel
• 金额: $ 15.09万
• 依托单位: MEDICAL COLLEGE OF WISCONSIN
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-01-15 至 2022-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10080367
• 关键词: Advisory Committees; Agonist; Apoptosis; Award; Biochemical; Biochemistry; Biology; Body Weight decreased; Cardiac; Cardiac Myocytes; Cardiomyopathies; Cardiovascular system; Clinical; Clinical Sciences; Development; Disease; Engineering; Environment; Extramural Activities; Fibrosis; Functional disorder; Funding; GLP-I receptor; Gastrectomy; Gastrointestinal Hormones; Goals; Heart Diseases; Heart failure; Human; In Vitro; Institutes; Intervention; Investigation; K-Series Research Career Programs; Lead; Mediating; Mentors; Mentorship; Messenger RNA; Metabolic; Metabolic stress; Modeling; Molecular; Morbid Obesity; Muscle Cells; Myocardial dysfunction; Myocardium; Nuclear Receptors; Obesity; Operative Surgical Procedures; PPAR alpha; Pathogenesis; Pathway interactions; Physiological; Pluripotent Stem Cells; Rattus; Receptor Activation; Receptor Signaling; Recovery; Recovery of Function; Regulation; Research; Research Personnel; Resources; Risk; Role; SLC2A1 gene; Serum; Signal Pathway; Signal Transduction; Stress; Structure; Techniques; Testing; Training; Training Programs; Transgenic Organisms; Translating; Translational Research; United States National Institutes of Health; Wisconsin; bariatric surgery; cell injury; collaborative environment; dieting; fatty acid oxidation; glucagon-like peptide 1; heart disease risk; heart function; hemodynamics; improved; in vivo; insulin signaling; medical schools; novel; obese patients; obese person; obesity treatment; oxidation; skills; stem cell technology

Project Summary Obesity cardiomyopathy is an increasingly prevalent and morbid disease of myocyte dysfunction causing heart failure due to severe obesity. Even though weight reduction through dieting fails to improve cardiac function, obesity treatment with bariatric surgery, like a sleeve gastrectomy (SG), significantly improves cardiac function. The inciting mechanisms for cardiac recovery after SG are poorly understood. This project will explore the novel hypothesis that cardiac glucagon-like peptide-1 receptor (GLP-1R) signaling results in the activation of the nuclear receptor peroxisome proliferator activated receptor alpha (PPARα), resulting in improved cardiac function. The applicant has found that a SG performed in obese rats significantly improved cardiac function, independent of weight loss, associated with increased serum GLP-1, increased cardiac PPARα, and decreased cardiac apoptosis, fibrosis and changes in substrate utilization. The specific aims of this proposal will test the hypothesis that cardiac GLP-1R stimulation activates PPARα resulting in decreased metabolic stress-induced apoptosis, fibrosis and increased β-oxidation and is the mechanism for cardiac recovery after SG. This award will produce a detailed understanding of cardiovascular pathophysiology, myocyte intracellular signaling pathways, biochemistry, and cardiac function analysis needed by the applicant. Further, this proposal allows for a rigorous training program to acquire the skills necessary to become a successful independent investigator with the mentorship of Dr. Corbett and the advisory committee. The primary goal of this mentored career development award is to determine the mechanisms for improved cardiac function after bariatric surgery and produce the preliminary studies needed to achieve extramural support via investigator initiated R01 funding by the NIH. The long-term scientific objective is to understand the mechanisms of interaction between bariatric surgery, obesity, and heart failure and translate these findings into surgical and non-surgical metabolic interventions. The Medical College of Wisconsin (MCW) provides an excellent environment for translational cardiovascular research. MCW's Cardiovascular Center and Clinical and Translational Science Institute provide excellent core resources and a strong collaborative environment to successfully perform the proposed studies and develop strong independent lines of investigation.

项目摘要 肥胖性心肌病是一种日益流行的心肌细胞功能障碍性疾病， 严重肥胖导致的心力衰竭。即使通过节食减肥不能改善心脏功能， 功能，减肥手术治疗肥胖，如袖状胃切除术（SG），显着改善心脏 功能SG后心脏恢复的刺激机制知之甚少。该项目将探索 心脏胰高血糖素样肽-1受体（GLP-1 R）信号转导导致 核受体过氧化物酶体增殖物激活受体α（PPARα），导致心脏 功能申请人已经发现，在肥胖大鼠中进行的SG显著改善了心脏功能， 与体重减轻无关，与血清GLP-1升高、心脏PPARα升高和 心肌细胞凋亡、纤维化和底物利用的变化。这项建议的具体目标将考验 假设心脏GLP-1 R刺激激活PPARα，导致代谢应激诱导的 细胞凋亡、纤维化和β-氧化增加是SG后心脏恢复的机制。这个奖项 将详细了解心血管病理生理学、肌细胞内信号传导 申请人所需的途径、生化和心功能分析。此外，该提案允许 严格的培训计划，以获得成为一名成功的独立调查员所需的技能， 科贝特博士和顾问委员会的指导这个职业生涯的主要目标 发展奖是为了确定减肥手术后改善心脏功能的机制， 通过研究者发起的R 01资助，开展获得院外支持所需的初步研究， 国家卫生研究院长期的科学目标是了解肥胖治疗与肥胖症之间的相互作用机制。 手术、肥胖和心力衰竭，并将这些发现转化为手术和非手术代谢 干预措施。威斯康星州医学院（MCW）为翻译提供了良好的环境， 心血管研究MCW的心血管中心和临床与转化科学研究所提供 优秀的核心资源和强大的合作环境，以成功地执行拟议的研究 并发展强大的独立调查线